These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2712862)

  • 1. Apolipoprotein E polymorphism and lipoproteins in insulin-treated diabetes mellitus.
    Winocour PH; Tetlow L; Durrington PN; Ishola M; Hillier V; Anderson DC
    Atherosclerosis; 1989 Feb; 75(2-3):167-73. PubMed ID: 2712862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
    Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
    Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.
    Kataoka S; Robbins DC; Cowan LD; Go O; Yeh JL; Devereux RB; Fabsitz RR; Lee ET; Welty TK; Howard BV
    Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):918-25. PubMed ID: 8696954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lipids, lipoproteins and apolipoprotein E phenotypes in relatives of patients with type III hyperlipoproteinaemia.
    Stuyt PM; Demacker PN; van 't Laar A
    Eur J Clin Invest; 1984 Jun; 14(3):219-26. PubMed ID: 6432551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein E isoprotein subclasses are genetically determined.
    Zannis VI; Just PW; Breslow JL
    Am J Hum Genet; 1981 Jan; 33(1):11-24. PubMed ID: 7468588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review.
    Eichner JE; Dunn ST; Perveen G; Thompson DM; Stewart KE; Stroehla BC
    Am J Epidemiol; 2002 Mar; 155(6):487-95. PubMed ID: 11882522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations.
    Ehnholm C; Lukka M; Kuusi T; Nikkilä E; Utermann G
    J Lipid Res; 1986 Mar; 27(3):227-35. PubMed ID: 3734624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients.
    Eggertsen G; Heimbürger O; Stenvinkel P; Berglund L
    Nephrol Dial Transplant; 1997 Jan; 12(1):141-4. PubMed ID: 9027789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX.
    Eichner JE; Ferrell RE; Kamboh MI; Kuller LH; Becker DJ; Drash AL; Stein EA; Orchard TJ
    Metabolism; 1992 Apr; 41(4):347-51. PubMed ID: 1556940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G
    Ric Clin Lab; 1982; 12(1):23-30. PubMed ID: 6283616
    [No Abstract]   [Full Text] [Related]  

  • 12. [Apolipoprotein E].
    Yamamura T
    Nihon Rinsho; 1994 Dec; 52(12):3124-32. PubMed ID: 7853700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients.
    Werle E; Fiehn W; Hasslacher C
    Diabetes Care; 1998 Jun; 21(6):994-8. PubMed ID: 9614620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E polymorphism in health and disease.
    Utermann G
    Am Heart J; 1987 Feb; 113(2 Pt 2):433-40. PubMed ID: 3544759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
    Imari Y; Koga S; Ibayashi H
    Metabolism; 1988 Dec; 37(12):1134-8. PubMed ID: 3193900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism influences lipid phenotypic expression, but not the low density lipoprotein subfraction distribution in familial combined hyperlipidemia.
    Bredie SJ; Vogelaar JM; Demacker PN; Stalenhoef AF
    Atherosclerosis; 1996 Oct; 126(2):313-24. PubMed ID: 8902157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes.
    Dullaart RP; Hoogenberg K; Riemens SC; Groener JE; van Tol A; Sluiter WJ; Stulp BK
    Diabetes; 1997 Dec; 46(12):2082-7. PubMed ID: 9392500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein abnormalities in insulin-dependent diabetes mellitus.
    Winocour PH; Durrington PN; Ishola M; Anderson DC
    Lancet; 1986 May; 1(8491):1176-8. PubMed ID: 2871420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum remnant lipoprotein cholesterol/triglyceride ratio as an index for screening familial type III hyperlipidaemia.
    Nakajima K; Daimon M; Kamiyama K; Takanashi K; Suzuki Y; Watanabe M; Kubono K; Saniabadi AR; Takashima S; Sakurabayashi I
    Ann Clin Biochem; 2007 Jul; 44(Pt 4):353-9. PubMed ID: 17663088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects.
    Rall SC; Weisgraber KH; Innerarity TL; Mahley RW
    Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4696-700. PubMed ID: 6289314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.